Related Experiment Video
Updated: Jan 2, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Tyrosinase inhibitors as potential antibacterial agents
Ye Yuan1, Wanli Jin2, Yasir Nazir2
1School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD, 4072, Australia.
Abstract:
Tyrosinase is a copper-containing enzyme that catalyzes the biosynthesis of melanin. This enzyme is present in bacteria, fungi, plants and animals, and plays multiple roles in pigmentation, wound healing, radiation protection, primary immune responses and the undesirable browning of fruits and vegetables. Selective tyrosinase inhibitors hence have potential application in diverse areas of agriculture, cosmetics and pharmaceuticals. In the past decade many natural and synthetic tyrosinase inhibitors have been evaluated, with many reported to also possess intrinsic antibacterial activity. Further, the enzyme product melanin has been shown to compromise the activity of traditional antibiotics. Due to the antibiotic resistance crisis and the slow development of new antibiotics, tyrosinase inhibitors may have potential for development of novel antimicrobials or antibiotic adjuvants that enhance activity of incumbent drugs. This review focuses on the antibacterial activity of natural and synthetic tyrosinase inhibitors reported in the past ten years and explores the possibilities for synergism of anti-tyrosinase with anti-bacterials.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antibiotic Selection
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

